Cargando…

Topiramate is more effective than acetazolamide at lowering intracranial pressure

BACKGROUND: The management of idiopathic intracranial hypertension focuses on reducing intracranial pressure to preserve vision and reduce headaches. There is sparse evidence to support the use of some of the drugs commonly used to manage idiopathic intracranial hypertension, therefore we propose to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scotton, William J, Botfield, Hannah F, Westgate, Connar SJ, Mitchell, James L, Yiangou, Andreas, Uldall, Maria S, Jensen, Rigmor H, Sinclair, Alex J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376637/ https://www.ncbi.nlm.nih.gov/pubmed/29898611 http://dx.doi.org/10.1177/0333102418776455

Ejemplares similares

Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension
por: Eftekhari, Sajedeh, et al.
Publicado: (2019)

Evaluating the Fat Distribution in Idiopathic Intracranial Hypertension Using Dual-Energy X-ray Absorptiometry Scanning
por: Hornby, Catherine, et al.
Publicado: (2017)

A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics
por: O’Reilly, Michael W., et al.
Publicado: (2019)

Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?
por: Yiangou, Andreas, et al.
Publicado: (2018)

Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
por: Westgate, Connar S.J., et al.
Publicado: (2021)

Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases
por: Markey, Keira A, et al.
Publicado: (2016)

Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension
por: Westgate, Connar Stanley James, et al.
Publicado: (2021)

Glucocorticoids modify intracranial pressure in freely moving rats
por: Westgate, Connar Stanley James, et al.
Publicado: (2023)

Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey
por: Scotton, William J, et al.
Publicado: (2018)

Long-term monitoring of intracranial pressure in freely-moving rats; impact of different physiological states
por: Eftekhari, Sajedeh, et al.
Publicado: (2020)

Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
por: Westgate, Connar S J, et al.
Publicado: (2022)

The impact of obesity-related raised intracranial pressure in rodents
por: Westgate, Connar Stanley James, et al.
Publicado: (2022)

11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial
por: Markey, Keira, et al.
Publicado: (2020)

11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
por: Hardy, Rowan S, et al.
Publicado: (2020)

Mechanism of Action of Acetazolamide and Idiopathic Intracranial Hypertension
por: Millichap, J. Gordon, et al.
Publicado: (2015)

Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial
por: Mollan, Susan P., et al.
Publicado: (2021)

Intraocular and intracranial pressure in glaucoma patients taking acetazolamide
por: Loiselle, Allison R., et al.
Publicado: (2020)

Resolution of Fulminant Idiopathic Intracranial Hypertension Treated with Acetazolamide
por: Srivastava, Ojas, et al.
Publicado: (2022)

High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure
por: Smith, Morgan B., et al.
Publicado: (2014)

Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache
por: Gracia-Naya, M, et al.
Publicado: (2013)

Cycle-dependent sex differences in expression of membrane proteins involved in cerebrospinal fluid secretion at rat choroid plexus
por: Israelsen, Ida Marchen Egerod, et al.
Publicado: (2023)

Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention
por: Hornby, Catherine, et al.
Publicado: (2018)

Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension
por: Aojula, Anuriti, et al.
Publicado: (2018)

Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
por: Mollan, Susan P, et al.
Publicado: (2016)

Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus
por: Barbuskaite, Dagne, et al.
Publicado: (2022)

Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol
por: Ottridge, Ryan, et al.
Publicado: (2017)

European Headache Federation guideline on idiopathic intracranial hypertension
por: Hoffmann, Jan, et al.
Publicado: (2018)

Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
por: Mollan, S. P., et al.
Publicado: (2021)

Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension
por: Mitchell, James L, et al.
Publicado: (2022)

Regression of Bilateral Peripapillary Choroidal Neovascularization Associated with Idiopathic Intracranial Hypertension after Systemic Acetazolamide Treatment
por: Trivizki, Omer, et al.
Publicado: (2022)

EHMTI-0165. Acetazolamide infusion induces immediate and delayed headache and intracranial artery dilatation in healthy volunteers
por: Arngrim, N, et al.
Publicado: (2014)

Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review
por: Goyal, Abhishek, et al.
Publicado: (2023)

Hypernatremia and intracranial pressure: more questions than answers
por: Griesdale, Donald EG, et al.
Publicado: (2013)

Acetazolamide Mitigates Intracranial Pressure Spikes Without Affecting Functional Outcome After Experimental Hemorrhagic Stroke
por: Williamson, Michael R., et al.
Publicado: (2018)

Response to “Acetazolamide and Cardiac Failure”
por: Imiela, Tomasz, et al.
Publicado: (2018)

Acetazolamide: Treatment of Psychogenic Polydipsia
por: Ahmed, Syed E, et al.
Publicado: (2017)

Stroke Mimic Caused by Acetazolamide
por: Mendes, Tiago Manuel
Publicado: (2018)

EHMTI-0077. Obesity-related intracranial hypertension in the rat – a possible idiopathic intracranial hypertension (IIH) model?
por: Uldall, M, et al.
Publicado: (2014)

There is more to NPH than lower body Parkinsonism
por: Oertel, Joachim M. K., et al.
Publicado: (2021)

Peripapillary Retinal Pigment Epithelium Layer Shape Changes From Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial
por: Wang, Jui-Kai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nr05m1pi6gvl4uqkf55qv6qmcb